Mark Pruzanski, CEO & President at INTERCEPT PHARMACEUTICALS INC (ICPT), sold 5,604 shares at $103.92 ($582K) on 2017-01-03, disclosed to the SEC on 2017-01-05.
Seasonal sale ($582k) by CEO & President — this insider has traded ICPT in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $103.92 | 2,802 | $291K | 50.0% |
| 2 | $103.92 | 2,802 | $291K | 50.0% |
| Total | $103.92 avg | 5,604 | $582K | 100% |
| Filing → |
| ICPT | SELL | 2019-11-27 | $5.0M | — | Filing → |
| ICPT | SELL | 2018-11-16 | $9.1M | — | Filing → |
| ICPT | BUY | 2018-04-09 | $500K | — | Filing → |